Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
批准号:
10206458
负责人:
Ankur Singh
金额:
$18.14万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-22 至 2022-12-31
关键词:
2019-nCoVAddressAffinityAnimal ModelAntibodiesAntibody FormationAntibody ResponseAntigen PresentationAntigen-Presenting CellsAntigensApoptoticAvidityB cell differentiationB-Cell Antigen ReceptorB-LymphocytesBiocompatible MaterialsBiomimeticsCell CommunicationCell Culture TechniquesCell Cycle ProgressionCell physiologyCellsConfocal MicroscopyDevelopmentDevicesEncapsulatedEngineeringEnzyme-Linked Immunosorbent AssayEpigenetic ProcessExploratory/Developmental GrantExposure toFlow CytometryFollicular Dendritic CellsFutureGenerationsGenetic EngineeringGoalsHaptensHybridomasHydrogelsImage CytometryImmuneImmune responseImmune systemImmunizeImmunoglobulin Class SwitchingImmunoglobulin Somatic HypermutationImmunoglobulin-Secreting CellsImmunologicsImmunotherapeutic agentInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeLightLiquid substanceLymphoid TissueMicrofluidicsModelingMolecularMolecular AnalysisMusNatureOrganoidsPatternPhenotypePlasma CellsProcessProliferatingReactionReportingSeriesStromal CellsStructure of germinal center of lymph nodeSurface Plasmon ResonanceSystemT-LymphocyteTechniquesTherapeutic AgentsTimeTissue EngineeringTissuesTransgenic MiceVaccinesbasecell motilitychemokinedesignextracellularhigh rewardhigh riskimmune functionin vivolymph nodesmigrationmultidisciplinaryoutcome predictionpathogenrapid testingresponsetranscriptometwo-photonvaccine candidatevaccine discovery
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Developing vaccines against emerging infections such as SARS-COV-2 and influenza requires an enhanced
understanding of the underlying antibody immune response in the body. Although antibodies, used as
therapeutic agents, can be derived from fused hybridoma models, animal models, or genetic engineering, these
techniques cannot explain the detailed immunological process of antibody formation and therefore, cannot
decipher or predict outcomes of host-pathogen interactions. The study of the mammalian immune system has
long been limited to in vivo approaches or single time point studies with limited donor lymphoid tissues, which
often do not allow multidimensional spatial and temporal control of intracellular and extracellular processes that
regulate the decisions of immune cells. This is attributable to the complexity of lymph nodes, which have distinct
niches of B and T cells, stromal cells, and antigen-presenting cells. When exposed to antigens, B cells undergo
a highly controlled activation process, called the germinal center (GC) reaction, which makes antigen-specific
antibody-secreting cells. Inside GCs, naïve B cells become activated, proliferate, migrate, undergo
immunoglobulin class switching, and increase their antigen affinity by somatic hypermutation and T cell-based
selection, yielding long-lived plasma cell with high affinity for specific antigens. However, the mechanistic
understanding of the GC process is largely derived from mouse lymph nodes or 2D B cell cultures, that do not
generate a bona fide GC response. The goal of this R21 is to develop an ImmuneChip platform that (A)
incorporates key molecular and cellular components of the lymph nodes to induce GC reactions and enable B
cell migration, (B) selects for high-affinity B cells through a forced affinity maturation process. The ImmuneChip
will provide multidimensional control of cellular processes in GCs, allow rapid generation of immune therapeutics,
and serve as a rapid testing platform to identify candidate vaccines and immunogens. The successful application
of this project will facilitate the rapid discovery of vaccine candidates for existing and emerging infections,
including lethal influenza and SARS-CoV-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
-
批准号:10669928
-
项目类别:
-
资助金额:$53.26万
-
财政年份:2023
-
负责人:Ankur Singh
-
依托单位:
Tissue-engineered Aged B Cell Immune Organoid to Study Antibody Secreting Cell Differentiation Trajectory
-
批准号:10804886
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2023
-
负责人:Ankur Singh
-
依托单位:
Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
-
批准号:10331889
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2021
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10656239
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10427259
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10206067
-
项目类别:
-
资助金额:$47.36万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:9885752
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
-
批准号:10247830
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2018
-
负责人:Ankur Singh
-
依托单位:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
-
批准号:10222176
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2018
-
负责人:Ankur Singh
-
依托单位:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
-
批准号:10330042
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2018
-
负责人:Ankur Singh
-
依托单位:
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
-
批准号:9233420
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2017
-
负责人:Ankur Singh
-
依托单位:
海外基金